In vitro studies have shown that selenium supplementation can inhibit viral infection by increasing glutathione peroxidase 1 (Gpx1) activity and reducing reactive oxygen species (ROS) content, JNK phosphorylation levels (57–59). Here, GPX1 is linked to viral infectious disease.